Navigation Links
Tengion Provides Business Update and Reports First Quarter 2011 Financial Results
Date:5/12/2011

to the US Renal Data System, the Medicare cost of hemodialysis is $77,000 per patient, per year and 100,000 ESRD patients die in the U.S. each year.  Tengion scientists have published and presented positive data on the effect of our approach on kidney function in four different preclinical models of CKD. Two of these preclinical models have been conducted for a sufficiently long period of time to demonstrate durability and an impact on survival.

Building on these results, Tengion is actively engaged in the next step in product development, defining product formulation and administration. The Company remains on track to request a pre-IND meeting with FDA by the end of the year.

"We are making progress with our Neo-Kidney Augment program and preclinical research, validating our formulation and delivery," said Tim Bertram, D.V.M., Ph.D., Executive Vice President, Science and Technology and Chief Scientific Officer. "We are on track to meet our goal of requesting a meeting with the FDA by the end of this year regarding the path to clinical trials with this development program."

In March, the Company announced the addition of two renal research and clinical experts, Ben Humphreys, M.D., Ph.D. and Giuseppe Remuzzi, M.D., F.R.C.P., from the Harvard Stem Cell Institute and Mario Negri Institute respectively, to its panel of Research & Development Advisors. This panel provides counsel to Tengion and engages leading researchers, clinicians, and patient advocates with the company as it advances its Organ Regeneration Platform™. The newest additions to the panel will work with Tengion in the area of renal function and CKD as the Company continues to advance its Neo-Kidney Augment program.

Financial Update  

For the three months ended March 31, 2011, the Company reported an adjusted net loss of $6.5 million, or $0.41 per basic and diluted common share, compared with an adjusted net loss of $6.6 million, or $1.04 p
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
2. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
3. Tengion Announces Second Closing of Series C Financing
4. Tengion to Present at the Piper Jaffray 20th Annual Healthcare Conference
5. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
6. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
7. Tengion Appoints A. Brian Davis Chief Financial Officer
8. Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010
9. Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
10. Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
11. Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 NuView Life Sciences (NLS), ... in vitro diagnostic (IVD) biomarkers, today announced the results ... screen in development for the early detection of Prostate ... an oral presentation at the 2013 Annual Meeting of ... in Vancouver, Canada on Sunday, June 9th. NLS ...
(Date:6/17/2013)... 2013 NASA deployed an ... helps better monitor potentially harmful chemicals in the air ... was developed by Draper Laboratory , is currently ... breathe air that is processed and re-circulated within the ... the air, even in trace amounts, endangers their health. ...
(Date:6/17/2013)... As a leader in the skincare industry, the team ... for acne, rosacea, and eczema. As part of Acne and ... Rosacea Society) has dedicated a month to creating awareness about ... on treatment options. Probiotic Action follows in the footsteps of ... via social networks and online resources for the acne and ...
(Date:6/17/2013)... Chicago, IL (PRWEB) June 17, 2013 ... carbohydrates for human health and nutrition, announced today ... has recently issued 2 patents - US 8,367,346 ... and US 8,338,147 entitled "Process for producing D-Mannitol." ... the fermentative production of natural food sweetener products ...
Breaking Biology Technology:NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 3New Monitoring System Will Better Protect NASA Astronauts on ISS 2Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions 2zuChem Receives Two Polyol Patents 2
... ISELIN, N.J., Feb. 26 SyntheMed, Inc. (OTC,Bulletin ... development,and commercialization of anti-adhesion products, drug delivery products ... Hickey, President,and CEO, will present at the Canaccord ... 3:30 p.m. PST in San Francisco, CA. Mr.,Hickey ...
... 26 Replidyne, Inc.,(Nasdaq: RDYN ) today announced its ... 31, 2007., Replidyne reported a net loss of $16.9 ... net loss per basic and diluted common share,of $0.63 per ... $0.36 per,basic and diluted common share, for the quarter ended ...
... published in February issue of Clinical and Vaccine Immunology, ... NanoBio,Corporation and the University of Michigan have demonstrated their ... the,potentially lethal dose of smallpox, and without the safety ... to smallpox virus,and builds immunity against it., The ...
Cached Biology Technology:Replidyne Announces 2007 Fourth Quarter and Full Year Results 2Replidyne Announces 2007 Fourth Quarter and Full Year Results 3Replidyne Announces 2007 Fourth Quarter and Full Year Results 4Replidyne Announces 2007 Fourth Quarter and Full Year Results 5Replidyne Announces 2007 Fourth Quarter and Full Year Results 6Replidyne Announces 2007 Fourth Quarter and Full Year Results 7Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 2Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks 3
(Date:6/17/2013)... 17, 2013 An international team led by scientists ... Medical Institute and Albert Einstein College of Medicine of ... compound that attacks the tuberculosis (TB) bacterium in two ... help solve one of the major global health crises ... drug-resistant strains," said Peter G. Schultz, the Scripps Family ...
(Date:6/17/2013)... Wayne State University,s Department of Physics kicked off ... for Undergraduates (REU) program. This program aims to ... in astrophysics, and in particle and nuclear physics. ... of physics in Wayne State,s College of Liberal ... the grant, the student participants will work with ...
(Date:6/17/2013)... understand the concept of improving original foundations with more ... the University of Pittsburgh,s Kenneth P. Dietrich School of ... that could make drug delivery, gas storage, and gas ... findings were reported in the latest issue of the ... JACS ). , The recent work builds upon Pitt ...
Breaking Biology News(10 mins):New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4Wayne State welcomes undergraduates from around the US for physics research experience 2'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... United States, smart growth proponents have urged communities to ... standard and familiar sprawl. Cluster developments create a ... portion of the land area than dispersed houses. ... open space, farmland, and rural character. Yet few ...
... D.C., Oct. 24, 2007 The vast majority ... the percutaneous MitraClip device did not need mitral ... many benefited from significantly improved function of the ... to data presented this week at the Cardiovascular ...
... priorities for biodiversity often focuses only on the numbers ... hemisphere or in the tropics. But what about ... the world, where the species richness of flowering plants ... UK and Chilean taxonomists, ecologists, and philosophers explored the ...
Cached Biology News:Location, location, location 2Location, location, location 3New data shows benefits of MitraClip for patients with mitral regurgitation 2New data shows benefits of MitraClip for patients with mitral regurgitation 3The conservation lens 2The conservation lens 3
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
Tissue culture grade....
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
IHC detection kit for PCNA in cells and tissues...
Biology Products: